Hospital El Cruce
16
1
1
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
6.3%
1 terminated/withdrawn out of 16 trials
83.3%
-3.2% vs industry average
6%
1 trials in Phase 3/4
20%
1 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Hemodynamic Profiles and Macro-Microcirculatory Coherence in Liver Transplantation: an Integrative Approach in the Immediate Postoperative Period
Role: lead
Role of Elastic Power in Acute Respiratory Distress Syndrome
Role: lead
Regional Assessment of the Risk of Lung Injury in Ventilated Patients
Role: lead
Implementation of a Re-engagement Program for Hepatitis C Patients Lost to Follow-up in Argentina.
Role: lead
Clinical and Atherosclerotic Characteristics of Patients With ACS Associated With Cocaine Use
Role: lead
Evaluation of the Efficacy and Safety of Midline Venous Catheters
Role: lead
Specific Mechanical Power Assessment in Patients With Acute Respiratory Distress Syndrome
Role: lead
Clinical and Biological Characterization of Post COVID-19 Syndrome
Role: collaborator
Ventilator-induced Lung Injury Vortex in Patients With SARS-CoV-2
Role: lead
Usefulness of the Variation of the CLIF-C ACLF Score in Patients With Acute on Chronic Liver Failure
Role: lead
Prolonged Vasospasm in Subarachnoid Hemorrhage
Role: lead
Immune Profile of Patients With Sepsis
Role: lead
The Role of Morphological Phenotype in ARDS
Role: lead
High-resolution Esophageal Manometry
Role: lead
Multi-cap for Increase Adherence After Acute Myocardial Infarction
Role: lead
Institutional Registry of Liver Transplantation
Role: lead
All 16 trials loaded